Brian Michael Bonnell, Chief Financial Officer of ICU Medical Inc/DE (NASDAQ:ICUI), filed a Form 4 on August 31, 2026, disclosing four separate dispositions of common stock on that same date, all executed under a Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Brian Michael Bonnell, Chief Financial Officer of ICU Medical Inc/DE
- Trading plan: All sales were made pursuant to a Rule 10b5-1 plan adopted on June 1, 2026
- First tranche: 1,712 shares disposed of at a weighted average price of $171.0532, with individual transaction prices ranging from $170.57 to $171.495
- Second tranche: 1,914 shares disposed of at a weighted average price of $172.1226, with prices ranging from $171.625 to $172.6
- Third tranche: 4,568 shares disposed of at a weighted average price of $173.4437, with prices ranging from $172.69 to $173.765
- Fourth tranche: 1,113 shares disposed of at a weighted average price of $173.9144, with prices ranging from $173.77 to $174.08
- Remaining direct ownership: 62,443 shares of common stock held directly, as reported following the final transaction
Four Share Dispositions Reported by ICU Medical's CFO Under a Pre-Established Plan
According to the filing, Bonnell disposed of common stock across four separately reported transactions, all dated August 31, 2026. Each transaction carried transaction code "S" (sale) and was recorded as a direct disposition. The filing notes that each reported price is a weighted average, and Bonnell undertakes to provide ICU Medical, any security holder, or SEC staff with full per-share transaction detail upon request.
The filing indicates that all sales reported in this Form 4 "were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026." ICU Medical Inc/DE is listed on NASDAQ under the symbol ICUI and is a medical device company incorporated in Delaware. The filing was signed by Paula Darbyshire as Attorney-in-Fact for Brian Bonnell and bears the date August 31, 2026.
Following the four reported dispositions, the filing states that Bonnell directly held 62,443 shares of common stock. No derivative securities transactions were reported in Table II of the filing. All ownership reported is classified as direct.
What Was Disclosed
The Form 4 filed August 31, 2026, discloses four dispositions of ICU Medical common stock by CFO Brian Michael Bonnell, totaling shares sold across four tranches with weighted average prices between $171.0532 and $173.9144, all under a pre-established Rule 10b5-1 plan.




Please wait processing your request...